Home・Stock List・CorMedix Inc

CorMedix Inc

Open

SectorHealthcare

7.49 -0.4

Buy Sell

Overview

Share price change

24h

Current

Min

7.44

Max

7.64

Key metrics
By Trading Economics
Income	25M 39M
Sales	-1.2M 127M
P/E Sector Avg	3.636 64.641
EPS	0.35
Profit margin	30.293
Employees	191
EBITDA	-289K 66M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+85.43% upside

Dividends
By Acuity
Next Earnings	13 Aug 2026

Market Stats
By TradingEconomics
Market Cap	-4.6M 596M
Previous open	7.89
Previous close	7.49

News Sentiment

By Acuity

100%

320 / 340 Healthcare

CorMedix Inc Chart

Past performance is not a reliable indicator of future results.

Related News

3 Aug 2026, 23:01 UTC

CorMedix Inc shares advanced in after-market trading, recovering from an earlier decline. The stock remains below its 20-day moving average and one-month range.

31 Jul 2026, 22:01 UTC

CorMedix Inc shares are lower in after-market hours, continuing a trend of weak trading. The stock is near its one-month low and below its 20-day average.

30 Jul 2026, 20:08 UTC

CorMedix Inc shares are trading higher, reflecting a notable early spike despite broader market volatility and mixed economic signals.

29 Jul 2026, 19:27 UTC

CorMedix Inc shares are lower today, continuing a four-session decline. The asset reached a session high before dropping to midday lows.

28 Jul 2026, 18:36 UTC

CorMedix Inc. shares are lower today amid broader market declines, influenced by significant drops in Asian indices, including the Nikkei 225 Index.

27 Jul 2026, 23:01 UTC

CorMedix Inc shares are higher in after-market trading, rising notably despite being below its 20-day moving average and near the lower end of its monthly range.

24 Jul 2026, 17:56 UTC

CorMedix Inc's shares are declining, with no specific news identified. The stock remains below its 20-day moving average and near the lower end of its one-month range.

23 Jul 2026, 21:51 UTC

CorMedix Inc shares declined in after-market trading, moving lower despite broader market resilience and turmoil in the bond market. No specific news was identified.

22 Jul 2026, 23:11 UTC

CorMedix Inc. shares are higher in after-market hours, following notable activity. The stock remains below its 20-day moving average.

21 Jul 2026, 19:31 UTC

CorMedix Inc. shares are higher today, reflecting strong buying activity. The stock has gained momentum since Monday's close, despite remaining below its 20-day moving average.

20 Jul 2026, 22:01 UTC

CorMedix Inc shares are higher in after-market trading, reflecting a notable rise since Monday's close, despite being below its 20-day moving average.

Peer Comparison

Price change

CorMedix Inc Forecast

Price Target

By TipRanks

85.43% upside

12 Months Forecast

Average 14 USD 85.43%

High 15 USD

Low 13 USD

Based on 5 Wall Street analysts offering 12 month price targets forCorMedix Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

Buy

Hold

Sell

Based on 5 analysts giving stock ratings to CorMedix Inc - Dist in the past 3 months.

Sentiment

By Acuity

320 / 340 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.